jCyte

About:

jCyte is a developer of cell-based technology intended to cure retinitis pigmentosa.

Website: http://www.jcyte.com

Twitter/X: j_cyte

Description:

jCyte is a developer of cell-based technology intended to cure retinitis pigmentosa. The company's therapy used retinal progenitor cells can secrete growth factors to rescue damaged retinal cells which help in treating a degenerative eye disease that ultimately causes blindness enabling, patients afflicted by conditions that lead to blindness, preserve and restore sight. They focused on the application of progenitor cell-based technology in retinal diseases.

Total Funding Amount:

$3.87M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Newport Beach, California, United States

Founded Date:

2012-01-10

Contact Email:

info(AT)jcyte.com

Founders:

Henry J. Klassen, Jing Yang

Number of Employees:

11-50

Last Funding Date:

2019-03-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai